8-K: Pennant Group to Acquire Signature Healthcare at Home Assets for $80 Million

The Pennant Group has agreed to purchase the assets of Signature Healthcare at Home for $80 million, expanding its presence in the Pacific Northwest.

Summary

• The Pennant Group, Inc. has announced an agreement to acquire the assets of certain affiliates of Signature Healthcare at Home for a total of $80 million.
• Signature Healthcare at Home is a provider of home health and hospice services in the Pacific Northwest, with operations in Oregon, Washington, and Idaho.
• Signature has over 650 employees, annual revenue of approximately $75 million, over 12,000 home health admissions, and an average daily hospice census of over 300 in the trailing twelve months.
• The acquisition is structured as two separate purchase agreements, with the Washington and Idaho assets expected to close on August 1, 2024, and the Oregon assets on January 1, 2025.
• The final purchase price is subject to adjustments based on potential changes in the business between signing and closing.
• This acquisition will expand Pennant's operational footprint in the Pacific Northwest, complementing its existing operations.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the strategic acquisition, expansion of operations, and positive comments from both companies' management. The deal is presented as a win-win for both parties.

Positives

• The acquisition will significantly expand Pennant's presence in the Pacific Northwest.
• Signature's locations, philosophy, and culture are considered a good fit with Pennant's existing operations.
• The deal is expected to provide growth opportunities for current and future operators within the Signature footprint.
• The acquisition will allow Pennant to implement its innovative operating model and leadership development programs.
• The acquisition will add seven locations in key population centers across Oregon.
• The acquisition will reinforce Pennant's leading position in Southwest Idaho.

Risks

• The final purchase price is subject to adjustments based on potential changes in the business between signing and closing.
• The acquisition is subject to customary closing conditions and regulatory approvals, which could potentially delay or prevent the deal from closing.

Future Outlook

Pennant will continue to pursue opportunities for growth in the home health, hospice, and senior living industries, targeting strategic and underperforming operations of all sizes.

Management Comments

• This is a significant acquisition in Pennant's history, said Brent Guerisoli, Pennant's Chief Executive Officer.
• We are excited to make this investment because of the quality of Signatures people and operations, continued Mr. Guerisoli.
• After twenty-five years of serving communities across the Pacific Northwest, we are excited to be acquired by Pennant, said Mary Kofstad, President of Signature Healthcare at Home.
• We have great respect for the talented team they have built and its impact on many communities across Oregon and Washington that we dont currently serve, said John Gochnour, Pennants President and Chief Operating Officer.

Industry Context

This acquisition reflects a trend of consolidation in the home health and hospice industry, as companies seek to expand their geographic reach and market share. Pennant's move to acquire Signature aligns with this trend, allowing them to strengthen their position in the Pacific Northwest.

Comparison to Industry Standards

• The acquisition of Signature Healthcare at Home for $80 million is a significant transaction in the home health and hospice sector, comparable to other regional acquisitions by larger players in the industry.
• The revenue multiple of approximately 1.07x (based on $75 million revenue) is within the typical range for acquisitions in this sector, although specific multiples can vary based on profitability, growth prospects, and geographic location.
• For example, acquisitions of similar sized regional home health and hospice providers have seen multiples ranging from 0.8x to 1.5x revenue, depending on the specific circumstances of the deal.
• Companies like LHC Group and Amedisys have also been active in acquiring smaller regional players to expand their market presence, indicating a broader trend of consolidation in the industry.

Stakeholder Impact

• Shareholders are likely to view the acquisition positively due to the potential for increased revenue and market share.
• Employees of Signature Healthcare at Home are expected to benefit from the transition with opportunities for professional and personal growth.
• Patients and communities served by Signature are expected to benefit from the additional support and resources provided by Pennant.
• The acquisition is expected to have a positive impact on the communities served by both companies.

Next Steps

• The acquisition of Washington and Idaho assets is expected to close on August 1, 2024.
• The acquisition of Oregon assets is expected to close on January 1, 2025.
• Pennant will integrate Signature's operations into its existing business.
• Pennant will continue to pursue opportunities for growth in the home health, hospice and senior living industries.

Key Dates

Keywords

acquisition, home health, hospice, healthcare, Pennant Group, Signature Healthcare, Pacific Northwest, merger